PHARMAZZ
Pharmazz they are focused on discovering, acquiring, developing, and commercializing therapeutics for care medicine.
PHARMAZZ
Industry:
Biotechnology Health Care Medical Pharmaceutical Service Industry
Founded:
2010-01-01
Address:
Willowbrook, Illinois, United States
Country:
United States
Website Url:
http://www.pharmazz.com
Total Employee:
11+
Status:
Active
Contact:
+1 (630)780-6087
Email Addresses:
[email protected]
Total Funding:
5.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome Google Maps COVID-19 Japanese Yen
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.pharmazz.com
- Host name: 209.8.63.50.host.secureserver.net
- IP address: 50.63.8.209
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Pharmazz"
Pharmazz, Inc has two products in late-stage clinical trials
Pharmazz, Inc. Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware Corporation based in Willowbrook, Illinois, USA focused …See details»
Pharmazz - Crunchbase Company Profile & Funding
Pharmazz is a Biopharmaceutical Company.Where is Pharmazz's headquarters? Pharmazz is located in Willowbrook, Illinois, United States. Who invested in …See details»
Pharmazz Company Profile - Office Locations, Competitors ... - Craft
Pharmazz has 5 employees across 2 locations. See insights on Pharmazz including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Pharmazz 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Pharmazz. Use the PitchBook Platform to explore the full profile.See details»
Pharmazz
About: Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware Corporation …See details»
Pharmazz, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 About Pharmazz, Inc. Pharmazz is a privately held company developing novel products in critical care medicine. Pharmazz obtained marketing authorization for two of its …See details»
Pharmazz Company Profile | Management and Employees List
Pharmazz Profile and History Pharmazz, Inc. is a privately-held company engaged in the development of novel products in the area of critical care medicine.See details»
PRESENTATION TITLE - pharmazz.com
Pharmazz, Inc. At A Glance Pharmazz is a late-stage biopharmaceutical company that addresses the underserved critical care market. It has two first-in-class drug candidates in Phase 3 in the …See details»
Pharmazz, Inc has two products in late-stage clinical trials
Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware Corporation based in Willowbrook, Illinois, USA focused on …See details»
Pharmazz - 2025 Company Profile - Tracxn
Jun 5, 2025 Pharmazz is a series C company based in Noida (India), founded in 2010 by Anil Gulati and Ajit Chand Srimal. It operates as a Clinical stage company developing critical care medicines. Pharmazz has raised $56.5M in …See details»
Pharmazz, Inc. Company Information - Funding, Investors, and More
Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine …See details»
Pharmazz, Inc. (Pharmazz, Inc.) - 药物管线_专利_临床试验_投融营 …
May 7, 2025 About Pharmazz, Inc. Pharmazz is a privately held company developing novel products in critical care medicine. Pharmazz obtained marketing authorization for two of its …See details»
Pharmazz Inc. Presents Data From its Positive Phase III
Sep 13, 2022 Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine (PMZ-2010) as a Resuscitative Agent in Hypovolemic Shock Patients at Upcoming Military …See details»
Press Releases | Pharmazz, Inc.
Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President WILLOWBROOK, Ill., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Pharmazz, Inc. ("Pharmazz" or …See details»
Pharmazz Inc. announces that Dr. Neil Marwah has joined the …
Sep 11, 2024 Prof. Anil Gulati, Chairman and CEO of Pharmazz, Inc., said, "Dr. Neil Marwah leaned in early to value-based care and value-based contracting, putting multiple …See details»
Pharmazz
Pharmazz, Inc. Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware …See details»
Pharmazz Inc. Announces Completion of Enrollment of Phase
Feb 17, 2022 Pharmazz Inc. Announces Completion of Enrollment of Phase III Clinical Trial Evaluating Sovateltide as a Treatment for Acute Cerebral Ischemic Stroke Sovateltide is an …See details»
Overview | Pharmazz, Inc.
Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline focused on discovering, acquiring, developing, and commercializing therapeutics …See details»
Investors | Pharmazz, Inc.
Investors Pharmazz is based in USA and engaged in developing and acquiring a broad and diverse pipeline of products related to critical care medicine. The company has a strong …See details»
Pharmazz Inc. Announces Positive Results of Phase III
May 25, 2022 The results have prompted Pharmazz to apply for marketing authorization from the Indian Central Drugs Standard Control Organization (CDSCO).See details»